Delphi Announces Diabetes Management SoftwareDeveloped in Collaboration withthe American Diabetes Association

02/22/2001

Delphi Health Systems, Inc. has announced the availability of the Delphi Diabetes Registry™, clinical support software for quality assessment and improvement in diabetes care. The program’s launch comes after an extensive development and testing period, followed by program advisory committee review and approval.

Delphi has developed the software in collaboration with the American Diabetes Association (ADA). The Delphi Diabetes Registry software is consistent with the ADA Standards of Care, may be used to apply for ADA Provider Recognition and supports the recently established National Standards for Diabetes Self-Management Education.

The Delphi Diabetes Registry software supports physicians and other members of the diabetes care team by fully automating the planning, delivery, management and ongoing quality assessment of patient care. The software conducts real-time monitoring of each patient’s care, integrates and measures the results of patient education, and provides an ongoing systematic assessment of clinical outcomes.

Richard Kahn, PhD, Chief Scientific and Medical Officer of the American Diabetes Association states, "The Delphi Diabetes Registry software has the potential to advance the quality of diabetes care by giving physicians and other care team members the critical information and tools they need to more effectively help their patients."

Ginger Kanzer-Lewis, RNC, EdM, CDE, president of GKL Associates, current president of the American Association of Diabetes Educators (AADE) and leader of the team that designed the education components of the program states, "I believe the Delphi Diabetes Registry will greatly assist its users in improving the quality of care they provide. I am excited about how the program gives us the up-to-date and complete information we need to help patients manage their diabetes, and how it produces the outcomes analysis that substantiates the value of our interventions. This is a special program that is going to have real impact."

At least 16 million Americans have diabetes and its costs exceed $100 billion annually. Diabetes is a leading cause of blindness, kidney failure, and amputations and dramatically raises the risk of heart attacks. It kills 180,000 Americans each year.

The share of the adult population diagnosed with diabetes jumped 33 percent nationally, to 6.5 percent, between 1990 and 1998, according to the Centers for Disease Control and Prevention (CDC). By 1999, it had risen to 6.9 percent. The CDC has concluded that this dramatic new evidence signals the unfolding of an epidemic in the United States.

Through the use of Delphi-developed software algorithms that automate the creation and implementation of standards-based guidelines, the diabetes clinical team selects the measures, parameters and thresholds that are used to collect, monitor and report the clinical status of all patients. The program assesses the status, measures the progress and reports the results for all patients under care. The program assures the delivery of standards-based, cost-efficient, quality diabetes care – delivered to the appropriate patient at the appropriate time.

The Registry software analyzes clinical results on an ongoing basis, producing alerts for results above established thresholds, reminders for scheduled tests and visits, and context-sensitive patient communication and education. The software includes a High-Risk Monitor that is active in the background of the program – building an ongoing high-risk patient assessment based on parameters set by the clinical team. This ongoing high-risk assessment creates an opportunity for earlier identification and intervention before the occurrence of high-expense care episodes.

The Delphi Diabetes Registry software is available immediately from Delphi Health Systems.

Delphi Health Systems, Inc. is a private software company based in Windsor, CT that is focused on the creation of clinical support software programs for diabetes and other chronic diseases. The Company has designed and developed a proprietary software architecture directed at the creation of programs that support the delivery and real-time monitoring of standards-based care for chronic diseases.